Related Experiment Video
Updated: Apr 28, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
26.0K
A Simple and Fast Protocol to Detect Nucleophosmin 1 (NPM1) Mutation and Fms-like Tyrosine Kinase 3 Internal Tandem
Alessandra Helena da Silva Hellwig1,2, Gisele Menezes Ewald3, Grazielle Motta Rodrigues1,2
1Residência Multidisciplinar em Área Profissional Análises Clínicas, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903, Brazil.
Methods and Protocols
|April 27, 2026
Summary
This study introduces a rapid multiplex PCR and capillary electrophoresis method for detecting key mutations in acute myeloid leukemia (AML). This approach aids diagnostic labs in classifying AML patients more accurately.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Acute myeloid leukemia (AML) is a complex blood cancer requiring precise classification.
- Current AML risk stratification relies heavily on cytogenetics, but ~45% of patients have a normal karyotype, complicating diagnosis.
- Identifying molecular markers is crucial for accurate risk and treatment stratification in AML.
Purpose of the Study:
- To present a simple, rapid multiplex PCR and capillary electrophoresis protocol.
- To detect two common molecular alterations in AML: NPM1 mutations and FLT3/ITD.
Main Methods:
- Development of a step-by-step multiplex PCR protocol.
- Integration with capillary electrophoresis for mutation detection.
- Focus on detecting nucleophosmin 1 (NPM1) mutations and FMS-like tyrosine kinase 3-internal tandem duplications (FLT3/ITD).
Main Results:
- A practical workflow for multiplex mutation detection in AML was established.
- The protocol enables the simultaneous detection of NPM1 and FLT3/ITD mutations.
- The method is designed for implementation in routine diagnostic laboratories.
Conclusions:
- The developed protocol offers a practical solution for routine molecular testing in AML.
- It supports more precise patient categorization into risk groups.
- This aids in optimizing diagnostic workflows for hematologic malignancies.
